Skip to main content
OpenTrials
Completed

NCT Number: NCT04819295

Latinx Teen Depression Treatment Study

The purpose of this study is determine facilitators of and barriers to receiving evidence-based psychotherapy for depression for Latinx adolescents from multiple stakeholder perspectives.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Depression Behavior Behavioral Symptoms

Age range

13 year–17 year

Sex eligibility

All sexes

Study type

Observational

Primary location

DUSON

Durham, North Carolina, 27707, United States

Who can participate

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Aged 13-17
  • self-identify as Hispanic/Latinx
  • diagnosed with Major Depressive Disorder or Persistent Depressive Disorder/Dysthymia
  • referred to psychotherapy or prescribed medication for depression.

Healthcare providers:

  • Self-identify as regularly providing clinical care to Latinx adolescents with depression
  • be in a role in which they can refer to or provide depression treatment.

Exclusion criteria

  • Teens will be excluded if they are experiencing intense psychological distress or imminent thoughts of suicide or have any condition in which, in the opinion of the investigator, precludes the study team from obtaining informed assent of the teen

Treatment and study plan

Primary outcomes

  1. Number of preferences for depression treatment generated from focus groups

    Time frame: Baseline

Secondary outcomes

  1. Number of barriers to depression treatment among Latinx Adolescents from focus groups

    Time frame: Baseline

Sponsors and collaborators

Lead sponsor

Duke University

Other

Registry information

Official study title

Barriers, Facilitators, and Preferences Regarding Depression Treatment From the Perspectives of Latinx Adolescents, Parents, and Healthcare Providers

Important dates

Study start
2021
Primary completion
2022
Study completion
2022
First posted
Mar 26, 2021
Registry last updated
Nov 8, 2022

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.